0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Inactivation Kits Market Research Report 2026
Published Date: 2026-01-07
|
Report Code: QYRE-Auto-8W8292
Home | Market Reports | Health| Medical Devices & Equipment
Global Viral Inactivation Kits Market Insights Forecast to 2028
BUY CHAPTERS

Global Viral Inactivation Kits Market Research Report 2026

Code: QYRE-Auto-8W8292
Report
2026-01-07
Pages:129
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Inactivation Kits Market Size

The global Viral Inactivation Kits market was valued at US$ 1209 million in 2025 and is anticipated to reach US$ 1979 million by 2032, at a CAGR of 7.3% from 2026 to 2032.

Viral Inactivation Kits Market

Viral Inactivation Kits Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Viral Inactivation Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global Viral Inactivation Kits production reached approximately 1,611.7 k kits with an average global market price of around US$750 per kit. Single-line annual production capacity averages 30 k units with a gross margin of approximately 40-45%. The upstream of Viral Inactivation Kits primarily consists of biopharmaceutical raw materials, chemical reagents, and instrumental equipment, concentrated in the field of biotechnology. Downstream applications are found in hospitals, scientific research, and diagnostic centers, with hospitals accounting for approximately 40% of consumption, scientific research at 30%, and diagnostic centers at 30%. The industry is experiencing sustained growth, with business opportunities primarily driven by the increasing demand for the prevention and treatment of viral diseases, the enhancement of standards in the biopharmaceutical industry, and the widespread application of Viral Inactivation Kits in global trade.
Viral Inactivation Kits are essential tools designed to neutralize viral contaminants through a robust and scientifically validated process, ensuring the complete destruction of viral structures and genetic material. These kits employ a combination of physical, chemical, or biological agents that disrupt the integrity of viruses, rendering them non-infectious and safe for further handling. By achieving thorough viral inactivation, these kits not only mitigate the risk of viral transmission but also preserve the quality and efficacy of the samples or products they are used on, making them indispensable in maintaining sterility and safety in various critical applications.
With the advancement of biotechnology and the heightened awareness of public health, Viral Inactivation Kits are experiencing a series of developmental trends, including technological innovation for enhanced efficiency and safety, standardization and regulation to ensure product quality and security, market globalization to expand service reach, diversification of applications into emerging fields such as vaccine production, sustained demand growth to address viral disease challenges, a focus on environmental protection and sustainability to reduce the ecological footprint, the provision of personalized services to meet varying user needs, and the application of digital and intelligent technologies to improve management efficiency and convenience. These trends collectively point towards a future for the Viral Inactivation Kits industry that is more efficient, secure, environmentally friendly, and tailored to individual requirements.
This report delivers a comprehensive overview of the global Viral Inactivation Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Viral Inactivation Kits. The Viral Inactivation Kits market size, estimates, and forecasts are provided in terms of sales volume (K Kits) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Viral Inactivation Kits market comprehensively. Regional market sizes by Type, by Application, by Sampling Method, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Viral Inactivation Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Viral Inactivation Kits Market Report

Report Metric Details
Report Name Viral Inactivation Kits Market
Accounted market size in 2025 US$ 1209 million
Forecasted market size in 2032 US$ 1979 million
CAGR 7.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Disposable Use
  • Reusable Use
Segment by Sampling Method
  • Pooled Sampling
  • Individual Sampling
Segment by Detected Target
  • Qualitative Detection
  • Quantitative Detection
by Application
  • Hospital
  • Scientific Research
  • Diagnostic Center
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Agilent Technologies, Qiagen, Merck, Danaher Corporation, Sartorius AG, HiMedia Laboratories, Maraval LifeSciences, Thermo Fisher Scientific, Seramun, Bio-Rad Antibodies, BTNX, DNA Genotek, CT Health, Medical Wire & Equipment, Youkang Biotechnology (Beijing), Beijing GenStar, Hefei Lake Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Sampling Method, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Viral Inactivation Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Viral Inactivation Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Viral Inactivation Kits Market growing?

Ans: The Viral Inactivation Kits Market witnessing a CAGR of 7.3% during the forecast period 2026-2032.

What is the Viral Inactivation Kits Market size in 2032?

Ans: The Viral Inactivation Kits Market size in 2032 will be US$ 1979 million.

Who are the main players in the Viral Inactivation Kits Market report?

Ans: The main players in the Viral Inactivation Kits Market are Agilent Technologies, Qiagen, Merck, Danaher Corporation, Sartorius AG, HiMedia Laboratories, Maraval LifeSciences, Thermo Fisher Scientific, Seramun, Bio-Rad Antibodies, BTNX, DNA Genotek, CT Health, Medical Wire & Equipment, Youkang Biotechnology (Beijing), Beijing GenStar, Hefei Lake Bio

What are the Application segmentation covered in the Viral Inactivation Kits Market report?

Ans: The Applications covered in the Viral Inactivation Kits Market report are Hospital, Scientific Research, Diagnostic Center

What are the Type segmentation covered in the Viral Inactivation Kits Market report?

Ans: The Types covered in the Viral Inactivation Kits Market report are Disposable Use, Reusable Use

1 Viral Inactivation Kits Market Overview
1.1 Product Definition
1.2 Viral Inactivation Kits by Type
1.2.1 Global Viral Inactivation Kits Market Value by Type: 2025 vs 2032
1.2.2 Disposable Use
1.2.3 Reusable Use
1.3 Viral Inactivation Kits by Sampling Method
1.3.1 Global Viral Inactivation Kits Market Value by Sampling Method: 2025 vs 2032
1.3.2 Pooled Sampling
1.3.3 Individual Sampling
1.4 Viral Inactivation Kits by Detected Target
1.4.1 Global Viral Inactivation Kits Market Value by Detected Target: 2025 vs 2032
1.4.2 Qualitative Detection
1.4.3 Quantitative Detection
1.5 Viral Inactivation Kits by Application
1.5.1 Global Viral Inactivation Kits Market Value by Application: 2025 vs 2032
1.5.2 Hospital
1.5.3 Scientific Research
1.5.4 Diagnostic Center
1.6 Global Viral Inactivation Kits Market Size Estimates and Forecasts
1.6.1 Global Viral Inactivation Kits Revenue 2021–2032
1.6.2 Global Viral Inactivation Kits Sales 2021–2032
1.6.3 Global Viral Inactivation Kits Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Viral Inactivation Kits Market Competition by Manufacturers
2.1 Global Viral Inactivation Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Viral Inactivation Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Viral Inactivation Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Viral Inactivation Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Viral Inactivation Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Viral Inactivation Kits, Product Types and Applications
2.7 Global Key Manufacturers of Viral Inactivation Kits, Date of Entry into the Industry
2.8 Global Viral Inactivation Kits Market Competitive Situation and Trends
2.8.1 Global Viral Inactivation Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Viral Inactivation Kits Players Market Share by Revenue
2.8.3 Global Viral Inactivation Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Viral Inactivation Kits Market Scenario by Region
3.1 Global Viral Inactivation Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Viral Inactivation Kits Sales by Region: 2021–2032
3.2.1 Global Viral Inactivation Kits Sales by Region: 2021–2026
3.2.2 Global Viral Inactivation Kits Sales by Region: 2027–2032
3.3 Global Viral Inactivation Kits Revenue by Region: 2021–2032
3.3.1 Global Viral Inactivation Kits Revenue by Region: 2021–2026
3.3.2 Global Viral Inactivation Kits Revenue by Region: 2027–2032
3.4 North America Viral Inactivation Kits Market Facts & Figures by Country
3.4.1 North America Viral Inactivation Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Viral Inactivation Kits Sales by Country (2021–2032)
3.4.3 North America Viral Inactivation Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Viral Inactivation Kits Market Facts & Figures by Country
3.5.1 Europe Viral Inactivation Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Viral Inactivation Kits Sales by Country (2021–2032)
3.5.3 Europe Viral Inactivation Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Viral Inactivation Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Viral Inactivation Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Viral Inactivation Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Viral Inactivation Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Viral Inactivation Kits Market Facts & Figures by Country
3.7.1 Latin America Viral Inactivation Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Viral Inactivation Kits Sales by Country (2021–2032)
3.7.3 Latin America Viral Inactivation Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Viral Inactivation Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Viral Inactivation Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Viral Inactivation Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Viral Inactivation Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Viral Inactivation Kits Sales by Type (2021–2032)
4.1.1 Global Viral Inactivation Kits Sales by Type (2021–2026)
4.1.2 Global Viral Inactivation Kits Sales by Type (2027–2032)
4.1.3 Global Viral Inactivation Kits Sales Market Share by Type (2021–2032)
4.2 Global Viral Inactivation Kits Revenue by Type (2021–2032)
4.2.1 Global Viral Inactivation Kits Revenue by Type (2021–2026)
4.2.2 Global Viral Inactivation Kits Revenue by Type (2027–2032)
4.2.3 Global Viral Inactivation Kits Revenue Market Share by Type (2021–2032)
4.3 Global Viral Inactivation Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Viral Inactivation Kits Sales by Application (2021–2032)
5.1.1 Global Viral Inactivation Kits Sales by Application (2021–2026)
5.1.2 Global Viral Inactivation Kits Sales by Application (2027–2032)
5.1.3 Global Viral Inactivation Kits Sales Market Share by Application (2021–2032)
5.2 Global Viral Inactivation Kits Revenue by Application (2021–2032)
5.2.1 Global Viral Inactivation Kits Revenue by Application (2021–2026)
5.2.2 Global Viral Inactivation Kits Revenue by Application (2027–2032)
5.2.3 Global Viral Inactivation Kits Revenue Market Share by Application (2021–2032)
5.3 Global Viral Inactivation Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Agilent Technologies
6.1.1 Agilent Technologies Company Information
6.1.2 Agilent Technologies Description and Business Overview
6.1.3 Agilent Technologies Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Agilent Technologies Viral Inactivation Kits Product Portfolio
6.1.5 Agilent Technologies Recent Developments/Updates
6.2 Qiagen
6.2.1 Qiagen Company Information
6.2.2 Qiagen Description and Business Overview
6.2.3 Qiagen Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Qiagen Viral Inactivation Kits Product Portfolio
6.2.5 Qiagen Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck Viral Inactivation Kits Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Danaher Corporation
6.4.1 Danaher Corporation Company Information
6.4.2 Danaher Corporation Description and Business Overview
6.4.3 Danaher Corporation Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Danaher Corporation Viral Inactivation Kits Product Portfolio
6.4.5 Danaher Corporation Recent Developments/Updates
6.5 Sartorius AG
6.5.1 Sartorius AG Company Information
6.5.2 Sartorius AG Description and Business Overview
6.5.3 Sartorius AG Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sartorius AG Viral Inactivation Kits Product Portfolio
6.5.5 Sartorius AG Recent Developments/Updates
6.6 HiMedia Laboratories
6.6.1 HiMedia Laboratories Company Information
6.6.2 HiMedia Laboratories Description and Business Overview
6.6.3 HiMedia Laboratories Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 HiMedia Laboratories Viral Inactivation Kits Product Portfolio
6.6.5 HiMedia Laboratories Recent Developments/Updates
6.7 Maraval LifeSciences
6.7.1 Maraval LifeSciences Company Information
6.7.2 Maraval LifeSciences Description and Business Overview
6.7.3 Maraval LifeSciences Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Maraval LifeSciences Viral Inactivation Kits Product Portfolio
6.7.5 Maraval LifeSciences Recent Developments/Updates
6.8 Thermo Fisher Scientific
6.8.1 Thermo Fisher Scientific Company Information
6.8.2 Thermo Fisher Scientific Description and Business Overview
6.8.3 Thermo Fisher Scientific Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Thermo Fisher Scientific Viral Inactivation Kits Product Portfolio
6.8.5 Thermo Fisher Scientific Recent Developments/Updates
6.9 Seramun
6.9.1 Seramun Company Information
6.9.2 Seramun Description and Business Overview
6.9.3 Seramun Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Seramun Viral Inactivation Kits Product Portfolio
6.9.5 Seramun Recent Developments/Updates
6.10 Bio-Rad Antibodies
6.10.1 Bio-Rad Antibodies Company Information
6.10.2 Bio-Rad Antibodies Description and Business Overview
6.10.3 Bio-Rad Antibodies Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Bio-Rad Antibodies Viral Inactivation Kits Product Portfolio
6.10.5 Bio-Rad Antibodies Recent Developments/Updates
6.11 BTNX
6.11.1 BTNX Company Information
6.11.2 BTNX Description and Business Overview
6.11.3 BTNX Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 BTNX Viral Inactivation Kits Product Portfolio
6.11.5 BTNX Recent Developments/Updates
6.12 DNA Genotek
6.12.1 DNA Genotek Company Information
6.12.2 DNA Genotek Description and Business Overview
6.12.3 DNA Genotek Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 DNA Genotek Viral Inactivation Kits Product Portfolio
6.12.5 DNA Genotek Recent Developments/Updates
6.13 CT Health
6.13.1 CT Health Company Information
6.13.2 CT Health Description and Business Overview
6.13.3 CT Health Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 CT Health Viral Inactivation Kits Product Portfolio
6.13.5 CT Health Recent Developments/Updates
6.14 Medical Wire & Equipment
6.14.1 Medical Wire & Equipment Company Information
6.14.2 Medical Wire & Equipment Description and Business Overview
6.14.3 Medical Wire & Equipment Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Medical Wire & Equipment Viral Inactivation Kits Product Portfolio
6.14.5 Medical Wire & Equipment Recent Developments/Updates
6.15 Youkang Biotechnology (Beijing)
6.15.1 Youkang Biotechnology (Beijing) Company Information
6.15.2 Youkang Biotechnology (Beijing) Description and Business Overview
6.15.3 Youkang Biotechnology (Beijing) Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Youkang Biotechnology (Beijing) Viral Inactivation Kits Product Portfolio
6.15.5 Youkang Biotechnology (Beijing) Recent Developments/Updates
6.16 Beijing GenStar
6.16.1 Beijing GenStar Company Information
6.16.2 Beijing GenStar Description and Business Overview
6.16.3 Beijing GenStar Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Beijing GenStar Viral Inactivation Kits Product Portfolio
6.16.5 Beijing GenStar Recent Developments/Updates
6.17 Hefei Lake Bio
6.17.1 Hefei Lake Bio Company Information
6.17.2 Hefei Lake Bio Description and Business Overview
6.17.3 Hefei Lake Bio Viral Inactivation Kits Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Hefei Lake Bio Viral Inactivation Kits Product Portfolio
6.17.5 Hefei Lake Bio Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Viral Inactivation Kits Industry Chain Analysis
7.2 Viral Inactivation Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Viral Inactivation Kits Production Mode & Process Analysis
7.4 Viral Inactivation Kits Sales and Marketing
7.4.1 Viral Inactivation Kits Sales Channels
7.4.2 Viral Inactivation Kits Distributors
7.5 Viral Inactivation Kits Customer Analysis
8 Viral Inactivation Kits Market Dynamics
8.1 Viral Inactivation Kits Industry Trends
8.2 Viral Inactivation Kits Market Drivers
8.3 Viral Inactivation Kits Market Challenges
8.4 Viral Inactivation Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Viral Inactivation Kits Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Viral Inactivation Kits Market Value by Sampling Method (US$ Million), 2025 vs 2032
 Table 3. Global Viral Inactivation Kits Market Value by Detected Target (US$ Million), 2025 vs 2032
 Table 4. Global Viral Inactivation Kits Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Viral Inactivation Kits Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Viral Inactivation Kits Sales (K Kits) of Key Manufacturers (2021–2026)
 Table 7. Global Viral Inactivation Kits Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Viral Inactivation Kits Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Viral Inactivation Kits Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Viral Inactivation Kits Average Price (US$/Kit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Viral Inactivation Kits, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Viral Inactivation Kits, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Viral Inactivation Kits, Product Types and Applications
 Table 14. Global Key Manufacturers of Viral Inactivation Kits, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Viral Inactivation Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Viral Inactivation Kits Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Viral Inactivation Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Viral Inactivation Kits Sales by Region (K Kits), 2021–2026
 Table 20. Global Viral Inactivation Kits Sales Market Share by Region (2021–2026)
 Table 21. Global Viral Inactivation Kits Sales by Region (K Kits), 2027–2032
 Table 22. Global Viral Inactivation Kits Sales Market Share by Region (2027–2032)
 Table 23. Global Viral Inactivation Kits Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Viral Inactivation Kits Revenue Market Share by Region (2021–2026)
 Table 25. Global Viral Inactivation Kits Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Viral Inactivation Kits Revenue Market Share by Region (2027–2032)
 Table 27. North America Viral Inactivation Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Viral Inactivation Kits Sales by Country (K Kits), 2021–2026
 Table 29. North America Viral Inactivation Kits Sales by Country (K Kits), 2027–2032
 Table 30. North America Viral Inactivation Kits Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Viral Inactivation Kits Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Viral Inactivation Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Viral Inactivation Kits Sales by Country (K Kits), 2021–2026
 Table 34. Europe Viral Inactivation Kits Sales by Country (K Kits), 2027–2032
 Table 35. Europe Viral Inactivation Kits Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Viral Inactivation Kits Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Viral Inactivation Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Viral Inactivation Kits Sales by Region (K Kits), 2021–2026
 Table 39. Asia Pacific Viral Inactivation Kits Sales by Region (K Kits), 2027–2032
 Table 40. Asia Pacific Viral Inactivation Kits Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Viral Inactivation Kits Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Viral Inactivation Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Viral Inactivation Kits Sales by Country (K Kits), 2021–2026
 Table 44. Latin America Viral Inactivation Kits Sales by Country (K Kits), 2027–2032
 Table 45. Latin America Viral Inactivation Kits Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Viral Inactivation Kits Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Viral Inactivation Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Viral Inactivation Kits Sales by Country (K Kits), 2021–2026
 Table 49. Middle East and Africa Viral Inactivation Kits Sales by Country (K Kits), 2027–2032
 Table 50. Middle East and Africa Viral Inactivation Kits Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Viral Inactivation Kits Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Viral Inactivation Kits Sales (K Kits) by Type (2021–2026)
 Table 53. Global Viral Inactivation Kits Sales (K Kits) by Type (2027–2032)
 Table 54. Global Viral Inactivation Kits Sales Market Share by Type (2021–2026)
 Table 55. Global Viral Inactivation Kits Sales Market Share by Type (2027–2032)
 Table 56. Global Viral Inactivation Kits Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Viral Inactivation Kits Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Viral Inactivation Kits Revenue Market Share by Type (2021–2026)
 Table 59. Global Viral Inactivation Kits Revenue Market Share by Type (2027–2032)
 Table 60. Global Viral Inactivation Kits Price (US$/Kit) by Type (2021–2026)
 Table 61. Global Viral Inactivation Kits Price (US$/Kit) by Type (2027–2032)
 Table 62. Global Viral Inactivation Kits Sales (K Kits) by Application (2021–2026)
 Table 63. Global Viral Inactivation Kits Sales (K Kits) by Application (2027–2032)
 Table 64. Global Viral Inactivation Kits Sales Market Share by Application (2021–2026)
 Table 65. Global Viral Inactivation Kits Sales Market Share by Application (2027–2032)
 Table 66. Global Viral Inactivation Kits Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Viral Inactivation Kits Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Viral Inactivation Kits Revenue Market Share by Application (2021–2026)
 Table 69. Global Viral Inactivation Kits Revenue Market Share by Application (2027–2032)
 Table 70. Global Viral Inactivation Kits Price (US$/Kit) by Application (2021–2026)
 Table 71. Global Viral Inactivation Kits Price (US$/Kit) by Application (2027–2032)
 Table 72. Agilent Technologies Company Information
 Table 73. Agilent Technologies Description and Business Overview
 Table 74. Agilent Technologies Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 75. Agilent Technologies Viral Inactivation Kits Product
 Table 76. Agilent Technologies Recent Developments/Updates
 Table 77. Qiagen Company Information
 Table 78. Qiagen Description and Business Overview
 Table 79. Qiagen Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 80. Qiagen Viral Inactivation Kits Product
 Table 81. Qiagen Recent Developments/Updates
 Table 82. Merck Company Information
 Table 83. Merck Description and Business Overview
 Table 84. Merck Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 85. Merck Viral Inactivation Kits Product
 Table 86. Merck Recent Developments/Updates
 Table 87. Danaher Corporation Company Information
 Table 88. Danaher Corporation Description and Business Overview
 Table 89. Danaher Corporation Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 90. Danaher Corporation Viral Inactivation Kits Product
 Table 91. Danaher Corporation Recent Developments/Updates
 Table 92. Sartorius AG Company Information
 Table 93. Sartorius AG Description and Business Overview
 Table 94. Sartorius AG Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 95. Sartorius AG Viral Inactivation Kits Product
 Table 96. Sartorius AG Recent Developments/Updates
 Table 97. HiMedia Laboratories Company Information
 Table 98. HiMedia Laboratories Description and Business Overview
 Table 99. HiMedia Laboratories Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 100. HiMedia Laboratories Viral Inactivation Kits Product
 Table 101. HiMedia Laboratories Recent Developments/Updates
 Table 102. Maraval LifeSciences Company Information
 Table 103. Maraval LifeSciences Description and Business Overview
 Table 104. Maraval LifeSciences Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 105. Maraval LifeSciences Viral Inactivation Kits Product
 Table 106. Maraval LifeSciences Recent Developments/Updates
 Table 107. Thermo Fisher Scientific Company Information
 Table 108. Thermo Fisher Scientific Description and Business Overview
 Table 109. Thermo Fisher Scientific Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 110. Thermo Fisher Scientific Viral Inactivation Kits Product
 Table 111. Thermo Fisher Scientific Recent Developments/Updates
 Table 112. Seramun Company Information
 Table 113. Seramun Description and Business Overview
 Table 114. Seramun Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 115. Seramun Viral Inactivation Kits Product
 Table 116. Seramun Recent Developments/Updates
 Table 117. Bio-Rad Antibodies Company Information
 Table 118. Bio-Rad Antibodies Description and Business Overview
 Table 119. Bio-Rad Antibodies Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 120. Bio-Rad Antibodies Viral Inactivation Kits Product
 Table 121. Bio-Rad Antibodies Recent Developments/Updates
 Table 122. BTNX Company Information
 Table 123. BTNX Description and Business Overview
 Table 124. BTNX Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 125. BTNX Viral Inactivation Kits Product
 Table 126. BTNX Recent Developments/Updates
 Table 127. DNA Genotek Company Information
 Table 128. DNA Genotek Description and Business Overview
 Table 129. DNA Genotek Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 130. DNA Genotek Viral Inactivation Kits Product
 Table 131. DNA Genotek Recent Developments/Updates
 Table 132. CT Health Company Information
 Table 133. CT Health Description and Business Overview
 Table 134. CT Health Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 135. CT Health Viral Inactivation Kits Product
 Table 136. CT Health Recent Developments/Updates
 Table 137. Medical Wire & Equipment Company Information
 Table 138. Medical Wire & Equipment Description and Business Overview
 Table 139. Medical Wire & Equipment Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 140. Medical Wire & Equipment Viral Inactivation Kits Product
 Table 141. Medical Wire & Equipment Recent Developments/Updates
 Table 142. Youkang Biotechnology (Beijing) Company Information
 Table 143. Youkang Biotechnology (Beijing) Description and Business Overview
 Table 144. Youkang Biotechnology (Beijing) Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 145. Youkang Biotechnology (Beijing) Viral Inactivation Kits Product
 Table 146. Youkang Biotechnology (Beijing) Recent Developments/Updates
 Table 147. Beijing GenStar Company Information
 Table 148. Beijing GenStar Description and Business Overview
 Table 149. Beijing GenStar Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 150. Beijing GenStar Viral Inactivation Kits Product
 Table 151. Beijing GenStar Recent Developments/Updates
 Table 152. Hefei Lake Bio Company Information
 Table 153. Hefei Lake Bio Description and Business Overview
 Table 154. Hefei Lake Bio Viral Inactivation Kits Sales (K Kits), Revenue (US$ Million), Price (US$/Kit), and Gross Margin (2021–2026)
 Table 155. Hefei Lake Bio Viral Inactivation Kits Product
 Table 156. Hefei Lake Bio Recent Developments/Updates
 Table 157. Key Raw Materials Lists
 Table 158. Raw Materials Key Suppliers Lists
 Table 159. Viral Inactivation Kits Distributors List
 Table 160. Viral Inactivation Kits Customers List
 Table 161. Viral Inactivation Kits Market Trends
 Table 162. Viral Inactivation Kits Market Drivers
 Table 163. Viral Inactivation Kits Market Challenges
 Table 164. Viral Inactivation Kits Market Restraints
 Table 165. Research Programs/Design for This Report
 Table 166. Key Data Information from Secondary Sources
 Table 167. Key Data Information from Primary Sources
 Table 168. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Viral Inactivation Kits
 Figure 2. Global Viral Inactivation Kits Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Viral Inactivation Kits Market Share by Type: 2025 & 2032
 Figure 4. Disposable Use Product Picture
 Figure 5. Reusable Use Product Picture
 Figure 6. Global Viral Inactivation Kits Market Value by Sampling Method (US$ Million), 2021–2032
 Figure 7. Global Viral Inactivation Kits Market Share by Sampling Method: 2025 vs 2032
 Figure 8. Pooled Sampling Product Picture
 Figure 9. Individual Sampling Product Picture
 Figure 10. Global Viral Inactivation Kits Market Value by Detected Target (US$ Million), 2021–2032
 Figure 11. Global Viral Inactivation Kits Market Share by Detected Target: 2025 vs 2032
 Figure 12. Qualitative Detection Product Picture
 Figure 13. Quantitative Detection Product Picture
 Figure 14. Global Viral Inactivation Kits Market Value by Application (US$ Million), 2021–2032
 Figure 15. Global Viral Inactivation Kits Market Share by Application: 2025 & 2032
 Figure 16. Hospital
 Figure 17. Scientific Research
 Figure 18. Diagnostic Center
 Figure 19. Global Viral Inactivation Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 20. Global Viral Inactivation Kits Market Size (US$ Million), 2021–2032
 Figure 21. Global Viral Inactivation Kits Sales (K Kits), 2021–2032
 Figure 22. Global Viral Inactivation Kits Average Price (US$/Kit), 2021–2032
 Figure 23. Viral Inactivation Kits Report Years Considered
 Figure 24. Viral Inactivation Kits Sales Share by Manufacturers in 2025
 Figure 25. Global Viral Inactivation Kits Revenue Share by Manufacturers in 2025
 Figure 26. Top 5 and Top 10 Global Viral Inactivation Kits Players: Market Share by Revenue in Viral Inactivation Kits in 2025
 Figure 27. Viral Inactivation Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 28. Global Viral Inactivation Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 29. North America Viral Inactivation Kits Sales Market Share by Country (2021–2032)
 Figure 30. North America Viral Inactivation Kits Revenue Market Share by Country (2021–2032)
 Figure 31. United States Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Canada Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Europe Viral Inactivation Kits Sales Market Share by Country (2021–2032)
 Figure 34. Europe Viral Inactivation Kits Revenue Market Share by Country (2021–2032)
 Figure 35. Germany Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. France Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. U.K. Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Italy Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Russia Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Asia Pacific Viral Inactivation Kits Sales Market Share by Region (2021–2032)
 Figure 41. Asia Pacific Viral Inactivation Kits Revenue Market Share by Region (2021–2032)
 Figure 42. China Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Japan Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. South Korea Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. India Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Australia Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. China Taiwan Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Indonesia Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Thailand Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Malaysia Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Latin America Viral Inactivation Kits Sales Market Share by Country (2021–2032)
 Figure 52. Latin America Viral Inactivation Kits Revenue Market Share by Country (2021–2032)
 Figure 53. Mexico Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Brazil Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Argentina Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Middle East and Africa Viral Inactivation Kits Sales Market Share by Country (2021–2032)
 Figure 57. Middle East and Africa Viral Inactivation Kits Revenue Market Share by Country (2021–2032)
 Figure 58. Turkey Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. Saudi Arabia Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. UAE Viral Inactivation Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Global Sales Market Share of Viral Inactivation Kits by Type (2021–2032)
 Figure 62. Global Revenue Market Share of Viral Inactivation Kits by Type (2021–2032)
 Figure 63. Global Viral Inactivation Kits Price (US$/Kit) by Type (2021–2032)
 Figure 64. Global Sales Market Share of Viral Inactivation Kits by Application (2021–2032)
 Figure 65. Global Revenue Market Share of Viral Inactivation Kits by Application (2021–2032)
 Figure 66. Global Viral Inactivation Kits Price (US$/Kit) by Application (2021–2032)
 Figure 67. Viral Inactivation Kits Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona